Free Disclosure Statement - District Court of Delaware - Delaware

Case 1 :07-cv—00432-GIVIS Document 2 Filed 07/11/2007 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
BOEHRINGER INGELHEIM PHARMA )
GMBH & CO. KG, DR. KARL THOMAE )
GMBH, BOEHRINGER INGELHEIM )
INTERNATIONAL GMBH, and )
BOEHRINGER INGELHEIM )
PHARMACEUTICALS, INC., )
)
Plaintiffs, ) C.A. N0.
)
v. )
)
BARR LABORATORIES, INC. and )
BARR PHARMACEUTICALS, INC., )
)
Defendants. )
PLAINTIFFS’ RULE 7.1 STATEMENT
Pursuant to Fed. R. Civ. P. 7.1, plaintiffs state that C. H. Boehringer Sohn directly
or indirectly owns plaintiff Boehringer Ingelheim Pharma GmbH & Co. KG, plaintiff Dr. Karl
Thomae GmbH, plaintiff Boehringer Ingelheim International GmbH, and plaintiff Boehringer
Ingelheim Pharmaceuticals, Inc. No publicly traded corporation owns more than 10% of any
plaintiff or C. H. Boehringer Sohn.
MORRIS, NICHOLS, ARSHT & TUNNEL LLP
/s/ Karen Jacobs Louden
Jack B. Blumenfeld (#1014)
Karen Jacobs Louden (#2881)
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899-1347
(302) 658-9200
[email protected]
[email protected]
Attornaysfor Plaintgjfs

Case 1:07-cv—00432-G|\/IS Document 2 Filed 07/11/2007 Page 2 of 2
OF COUNSEL:
Bruce M. Wexler
Joseph M, O’Malley, Jr.
Eric W. Dittmann
PAUL, HASTINGS, JANOFSKY & WALKER LLP
75 East 55th Street
New York, NY 10022
(212) 318-6000
July 11, 2007
952182
2